The Technical AnalystExchange: TAI Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Standard Chem & Pharm Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.16% TWD63.30
America/New_York / 3 mai 2024 @ 01:30
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 11 311 mill |
| EPS: | 4.74 |
| P/E: | 13.35 |
| Earnings Date: | May 07, 2024 |
| SharesOutstanding: | 178.70 mill |
| Avg Daily Volume: | 0.589 mill |
| RATING 2024-05-03 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.72x |
| Company: PE 13.35 | sector: PE 18.55 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.11x |
| Company: PE 13.35 | industry: PE 11.99 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
TWD131.73 (108.10%) TWD68.43 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
TWD 62.43 - 64.17 ( +/- 1.38%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | TWD63.30 (0.16% ) |
| Volume | 0.257 mill |
| Avg. Vol. | 0.589 mill |
| % of Avg. Vol | 43.69 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 1720.TW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
1720.TW
Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.